MeSH tree: D10.251.450.200
Every month, around 2.7 million Australians have a statin dispensed to lower their risk of heart attack and stroke. Statins reduce the risk of cardiovascular disease, the collective term for conditions involving the heart ...
Sep 14, 2026
0
13
Reducing the damage sustained by the heart during a myocardial infarction remains one of the major challenges in cardiology, even when the blocked coronary artery is reopened in a timely manner. Part of the myocardial injury ...
Jun 10, 2026
1
6
Alzheimer's disease (AD) is a neurodegenerative disorder that leads to progressive memory loss and a decline in mental functions. Several past studies have linked this disease to the accumulation of the protein amyloid-β ...
Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and acute kidney failure. However, there have been limitations in directly observing how muscle and kidney ...
Jan 6, 2026
0
15
Statins have transformed heart health, saving millions of lives by lowering cholesterol and reducing the risk of heart attacks and strokes. But for many patients, these drugs come with a troubling downside: muscle pain, weakness ...
Nov 26, 2025
0
786
If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.
Oct 30, 2025
0
95
A research team from the Department of Pathology at the University of Hong Kong's LKS Faculty of Medicine (HKUMed) has discovered that atorvastatin, a widely used cholesterol-lowering drug, could become a powerful new weapon ...
Sep 12, 2025
0
37
There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides both statistically significant and clinically meaningful benefits in treating and preventing cardiovascular ...
Jul 28, 2025
0
66
In February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV Guidelines Panel), in collaboration with the American College of Cardiology ...
May 26, 2025
0
24
There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29 in Annals of Internal Medicine.
Oct 30, 2024
0
65
